ASSOCATION DIABETES MELLITUS AND CELIAC DISEASE : A SYSTEMATIC REVIEW
DOI:
https://doi.org/10.53555/nnmhs.v8i12.1460Keywords:
Autoimmune, Celiac disease, Diabetes Mellitus, HyperglycemiaAbstract
The incidence of diabetes mellitus, a persistent metabolic condition, has been steadily climbing at an alarming rate all over the world. This condition represents a substantial danger to the wellbeing of people living in all parts of the world. Celiac disease is an immune-mediated condition that affects a person for their entire life. It is characterized by gluten-triggered inflammation and morphological damage of the small bowel mucosa in genetically susceptible individuals. Celiac disease can be prevented by avoiding foods that contain gluten. One of the surprising revelations that came out of this latest investigation was the realization that type 1 diabetes is significantly overrepresented in particular in males who have celiac disease. On the other hand, the prevalence of type 2 diabetes was practically identical to that of the overall Finnish population. People who have celiac disease and also have type 1 or type 2 diabetes are more likely to experience severe comorbidities, and type 1 diabetes is associated with a poorer rate of adherence to a gluten-free diet than celiac disease alone. 16 According to the findings of this study, patients who have type 1 diabetes have an incidence of CeD that is up to twice as high. This is connected to autoimmune disease, which is the pathophysiology of type 1 diabetes as well.
References
International Diabetes Federation. Diabetes. Brussels: IDF; 2017.
Fauci AS, Jameson JL, Kasper D, et al. Harrison’s Principles of Internal Medicine 19th Edition. New York: McGraw-Hill Education; 2018.
Fuchs V, Kurppa K, Huhtala H, Collin P, Mäki M, Kaukinen K. Factors associated with long diagnostic delay in celiac disease. Scand J Gastroenterol. 2014;49(11):1304–10.
Tye-Din JA, Galipeau HJ, Agardh D. Celiac Disease: A Review of Current Concepts in Pathogenesis, Prevention, and Novel Therapies. Front Pediatr. 2018;6:350–7.
Rubio-Tapia A, Murray JA. Celiac disease. Curr Opin Gastroenterol. 2010;26(2):116.
Lundin KEA, Sollid LM. Advances in coeliac disease. Curr Opin Gastroenterol. 2014;30(2):154–62.
Mustalahti K, Catassi C, Reunanen A, Fabiani E, Heier M, McMillan S, et al. The prevalence of celiac disease in Europe: results of a centralized, international mass screening project. Ann Med. 2010;42(8):587–95.
Kabbani TA, Kelly CP, Betensky RA, Hansen J, Pallav K, Villafuerte-Gálvez JA, et al. Patients with celiac disease have a lower prevalence of non-insulin-dependent diabetes mellitus and metabolic syndrome. Gastroenterology. Mei 2013;144(5):912-917.e1.
Smyth DJ, Plagnol V, Walker NM, Cooper JD, Downes K, Yang JHM, et al. Shared and distinct genetic variants in type 1 diabetes and celiac disease. N Engl J Med. Desember 2008;359(26):2767–77.
Kylökäs A, Kaukinen K, Huhtala H, Collin P, Mäki M, Kurppa K. Type 1 and type 2 diabetes in celiac disease: prevalence and effect on clinical and histological presentation. BMC Gastroenterol [Internet]. 2016;16(1):76. Tersedia pada: https://doi.org/10.1186/s12876-016-0488-2
Kizilgul M, Ozcelik O, Beysel S, Akinci H, Kan S, Ucan B, et al. Screening for celiac disease in poorly controlled type 2 diabetes mellitus: worth it or not? BMC Endocr Disord. Oktober 2017;17(1):62.
Craig ME, Prinz N, Boyle CT, Campbell FM, Jones TW, Hofer SE, et al. Prevalence of Celiac Disease in 52,721 Youth With Type 1 Diabetes: International Comparison Across Three Continents. Diabetes Care [Internet]. 25 Mei 2017;40(8):1034–40. Tersedia pada: https://doi.org/10.2337/dc16-2508
Deniz G, Yakut M, Tüzün Y, Tuzcu AK, Arikan S. The Prevalence of Celiac Disease in Patients with Diabetes Mellitus—The Prevalence of Celiac Disease. Int J Clin Med. 2011;2(03):201.
Elliott DE. The Pathophysiology of Celiac Disease BT - Celiac Disease. In: Rampertab SD, Mullin GE, editor. New York, NY: Springer New York; 2014. hal. 39–51. Tersedia pada: https://doi.org/10.1007/978-1-4614-8560-5_4
Harjutsalo V, Sund R, Knip M, Groop P-H. Incidence of type 1 diabetes in Finland. Jama. 2013;310(4):427–8.
Camarca ME, Mozzillo E, Nugnes R, Zito E, Falco M, Fattorusso V, et al. Celiac disease in type 1 diabetes mellitus. Ital J Pediatr. Maret 2012;38:10.
Nunes-Silva JG, Nunes VS, Schwartz RP, MLSS Trecco S, Evazian D, Correa-Giannella ML, et al. Impact of type 1 diabetes mellitus and celiac disease on nutrition and quality of life. Nutr Diabetes [Internet]. 2017;7(1):e239–e239. Tersedia pada: https://doi.org/10.1038/nutd.2016.43
Elfström P, Sundström J, Ludvigsson JF. Systematic review with meta?analysis: associations between coeliac disease and type 1 diabetes. Aliment Pharmacol Ther. 2014;40(10):1123–32.
Lohi S, Mustalahti K, Kaukinen K, Laurila K, Collin P, Rissanen H, et al. Increasing prevalence of coeliac disease over time. Aliment Pharmacol Ther. 2007;26(9):1217–25.
Weiss B, Pinhas-Hamiel O. Celiac disease and diabetes: when to test and treat. J Pediatr Gastroenterol Nutr. 2017;64(2):175–9.
Holmes GKT. Coeliac disease and type 1 diabetes mellitus–the case for screening. Diabet Med. 2001;18(3):169–77.
Rewers M, Liu E, Simmons J, Redondo MJ, Hoffenberg EJ. Celiac disease associated with type 1 diabetes mellitus. Endocrinol Metab Clin. 2004;33(1):197–214.
Downloads
Published
Issue
Section
License
Copyright (c) 2022 Journal of Advance Research in Medical & Health Science
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Licensing
Ninety Nine Publication publishes articles under the Creative Commons Attribution 4.0 International License (CC BY 4.0). This licensing allows for any use of the work, provided the original author(s) and source are credited, thereby facilitating the free exchange and use of research for the advancement of knowledge.
Detailed Licensing Terms
Attribution (BY): Users must give appropriate credit, provide a link to the license, and indicate if changes were made. Users may do so in any reasonable manner, but not in any way that suggests the licensor endorses them or their use.
No Additional Restrictions: Users may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
